Literature DB >> 11334351

Determination of lysophosphatidic acids by capillary electrophoresis with indirect ultraviolet detection.

Y L Chen1, Y Xu.   

Abstract

Lysophosphatidic acid (LPA) is the simplest form of lysophospholipid. Molecular species of LPA have been identified as the potent components in the ovarian cancer activation factor. The elevated plasma LPAs may be used as potential biomarkers for the early detection of ovarian cancer. This paper is the first report on the quantitative analysis of molecular species of LPA using capillary electrophoresis. In this work, the separation of LPAs was achieved within 14 min in an adenosine monophosphate-borate-methanol-water solution, and the measurement was accomplished by indirect UV detection. With LPA (D) as internal standard, the method had linear calibration ranges for LPAs from 2.8 to 75 microM. The detection limits for various molecular species of LPA were from 1.2 to 2.3 microM by the pressure injection at 3.45 kPa for 5 s. The method had been applied to serum fortified with LPA (S), LPA (O), LPA (P), and LPA (M) and the recoveries ranged from 83 to 112%.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334351     DOI: 10.1016/s0378-4347(00)00582-x

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  6 in total

1.  A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.

Authors:  Lesley A Ford; Anke J Roelofs; Sharon Anavi-Goffer; Luisa Mowat; Daniel G Simpson; Andrew J Irving; Michael J Rogers; Ann M Rajnicek; Ruth A Ross
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS.

Authors:  S P Bathena; J Huang; M E Nunn; T Miyamoto; L C Parrish; M S Lang; T P McVaney; M L Toews; D R Cerutis; Y Alnouti
Journal:  J Pharm Biomed Anal       Date:  2011-06-06       Impact factor: 3.935

3.  Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acid.

Authors:  Lei Wang; Martha Sibrian-Vazquez; Jorge O Escobedo; Jialu Wang; Richard G Moore; Robert M Strongin
Journal:  Chem Commun (Camb)       Date:  2015-01-31       Impact factor: 6.222

Review 4.  Roles of lysophosphatidic acid in cardiovascular physiology and disease.

Authors:  Susan S Smyth; Hsin-Yuan Cheng; Sumitra Miriyala; Manikandan Panchatcharam; Andrew J Morris
Journal:  Biochim Biophys Acta       Date:  2008-06-10

5.  Simple enrichment and analysis of plasma lysophosphatidic acids.

Authors:  Jialu Wang; Martha Sibrian-Vazquez; Jorge O Escobedo; Mark Lowry; Lei Wang; Yu-Hsuan Chu; Richard G Moore; Robert M Strongin
Journal:  Analyst       Date:  2013-11-21       Impact factor: 4.616

6.  Templated polymers enable selective capture and release of lysophosphatidic acid in human plasma via optimization of non-covalent binding to functional monomers.

Authors:  Jialu Wang; Martha Sibrian-Vazquez; Jorge O Escobedo; Lei Wang; Yu-Hsuan Chu; Richard G Moore; Robert M Strongin
Journal:  Analyst       Date:  2015-11-21       Impact factor: 4.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.